Your browser doesn't support javascript.
loading
Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates.
Booth, Georgeann; Yu, Yun; Harlan, Rogelyn P; Jacoby, Carol E; Tomic, Kaitlyn M; Slater, Susan E; Allen, Bryon E; Berklich, Elizabeth M; Knight, Rebekah J; Dela Cruz, Julieann; Fu, Rongwei; Gandhi, Arpita; Cook, Rachel J; Meyers, Gabrielle; Maziarz, Richard T; Newell, Laura F.
Afiliação
  • Booth G; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Yu Y; Biostatistics Shared Resources, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Harlan RP; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Jacoby CE; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Tomic KM; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Slater SE; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Allen BE; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Berklich EM; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Knight RJ; Cellular Therapy Laboratory, Hospital and Clinics, Oregon Health & Science University, Portland.
  • Dela Cruz J; Cellular Therapy Laboratory, Hospital and Clinics, Oregon Health & Science University, Portland.
  • Fu R; Biostatistics Shared Resources, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA; Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University-Portland State University School of Public Health, Oregon Health and Science Univers
  • Gandhi A; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Cook RJ; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Meyers G; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Maziarz RT; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Newell LF; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA. Electronic address: newelll@ohsu.edu.
Cytotherapy ; 25(4): 423-431, 2023 04.
Article em En | MEDLINE | ID: mdl-36690537
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article